Inside Your Health: Ozempic and Zepbound

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x

IYH: Weight loss Drugs

Two major FDA approvals could change the way we treat sleep apnea and diabetes-related kidney disease.

On Tuesday, the agency gave the green light for Ozempic to help protect kidney function in people with diabetes and Zepbound as the first-ever drug treatment for sleep apnea in people with obesity.

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr. Archelle Georgiou is here with more information.